Drug intelligence / Profile preview

trillium tschonoskii steroidal saponins

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Trillium tschonoskii steroidal saponins (TTS) are a group of bioactive compounds extracted from the rhizomes of the medicinal plant *Trillium tschonoskii* Maxim. These saponins have demonstrated potent anti-cancer properties, particularly against colorectal cancer, in preclinical models. The mechanism of action involves inhibiting cell proliferation and inducing apoptosis by suppressing the mitogen-activated protein kinase (MAPK) signaling pathways and activating the mitochondrial-mediated apoptotic pathway, which is characterized by increased caspase-3 activity. Major active components identified in the TTS extract include Paris saponin VII, polyphylloside III, and Paris saponin VI. Research indicates that TTS can significantly reduce tumor incidence and abnormal epithelial cell proliferation in mouse models of colitis-associated colorectal cancer.

Other names
Trillium tschonoskii saponinsSaponins of Trillium tschonoskii
02

Targets

CASP3 (Caspase-3)ABCB1 (P-glycoprotein)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MRP (Multidrug resistance-associated protein family)

Beyond the preview

Go deeper on trillium tschonoskii steroidal saponins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trillium tschonoskii steroidal saponins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call